Our Pricing

Wegovy UK In Stock - Next Day Cold-Chain Delivery

Published on: June 03, 2026

Searching for Wegovy UK in stock next day delivery? Cured Pharmacy maintains consistent stock of genuine UK-licensed Wegovy pens at £79.00, with specialist cold-chain delivery ensuring your medication arrives in optimal condition. Our UK-registered prescribers complete consultations in under 3 minutes, and orders approved before 3pm dispatch the same day.

Why Wegovy Availability Matters for Your Weight Loss Journey

Wegovy (semaglutide 2.4mg) has experienced significant supply challenges across UK pharmacies since its launch, leaving many patients unable to maintain their prescribed treatment schedule. Interruptions to your weekly injection routine can compromise the progressive dose escalation protocol that underpins Wegovy's clinical efficacy [1].

At Cured Pharmacy, we've invested in dedicated cold-chain storage and supplier relationships to maintain consistent Wegovy stock across all dose strengths. Our superintendent pharmacist Tarun Kumar personally oversees inventory management to ensure patients can access their prescribed doses without treatment gaps.

The STEP 1 trial demonstrated that consistent weekly semaglutide injections produced an average 14.9% body weight reduction over 68 weeks, but this outcome depends on uninterrupted treatment adherence [1]. Stock availability isn't just convenience—it's essential for achieving the clinical outcomes seen in regulatory trials.

How Our Cold-Chain Delivery Protects Your Wegovy Investment

Wegovy must be stored between 2°C and 8°C before first use to maintain semaglutide stability and efficacy. Standard parcel delivery exposes temperature-sensitive medications to ambient conditions that can degrade the active ingredient, potentially rendering your prescription ineffective.

We use specialist pharmaceutical couriers with validated cold-chain packaging—insulated containers with medical-grade gel packs that maintain the required temperature range for up to 48 hours. Every delivery includes a temperature indicator card so you can verify your Wegovy arrived in optimal condition.

Orders placed before 3pm Monday to Thursday are dispatched the same day for next-day delivery. Friday orders arrive Saturday via our weekend cold-chain service. This rapid turnaround means your Wegovy spends minimal time in transit, further protecting medication integrity.

What Happens If Wegovy Gets Too Warm?

If Wegovy is exposed to temperatures above 30°C or freezing conditions, the semaglutide molecule can denature, reducing its biological activity. The MHRA licensing conditions specify strict storage requirements precisely because temperature excursions compromise patient outcomes [2].

Our cold-chain process eliminates this risk. If your temperature indicator shows exposure outside the safe range (which occurs in less than 0.5% of deliveries), contact our pharmacy team immediately on (+44) 116 4646009 for a replacement at no additional cost.

Wegovy Pricing at Cured Pharmacy: Transparent and Competitive

Wegovy is available from £79.00 at Cured Pharmacy—a price you'll see upfront before starting your clinical consultation. Unlike some online services that reveal costs only after assessment, we believe transparency helps patients make informed decisions about their weight loss treatment.

This pricing includes your UK prescriber consultation, the genuine UK-licensed Wegovy pen, specialist cold-chain delivery, and ongoing support from our GPhC-registered pharmacy team. There are no hidden consultation fees or surprise charges at checkout.

We guarantee the lowest Wegovy prices in the UK. If you find a lower price at another UK-registered pharmacy for the same dose and service level, we'll match it. Our buying power and efficient online model allow us to pass savings directly to patients whilst maintaining the highest dispensing standards.

Understanding Wegovy Dosing: From 0.25mg to 2.4mg Maintenance

Wegovy treatment follows a mandatory dose escalation schedule over 16-20 weeks, starting at 0.25mg weekly and increasing gradually to the maintenance dose of 2.4mg. This protocol minimises gastrointestinal side effects whilst allowing your body to adapt to semaglutide's appetite-regulating effects [1].

The typical escalation pathway is: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), then 2.4mg maintenance. Your UK prescriber may adjust this timeline based on your tolerance and clinical response during follow-up assessments.

Stock availability across all dose strengths is critical because you cannot skip escalation steps or jump directly to 2.4mg. Our inventory management ensures continuity—when we dispense your starter dose, we've already confirmed stock of your subsequent doses to prevent treatment interruptions.

What If I Experience Side Effects During Escalation?

Nausea, diarrhoea, and constipation are common during the first 4-8 weeks as your body adjusts to semaglutide [2]. These effects typically resolve within 2-3 weeks of each dose increase. Our clinical team can extend your time at a lower dose if side effects persist, allowing your tolerance to develop before progressing.

Staying at a sub-maintenance dose temporarily is clinically appropriate and won't compromise your long-term outcomes. The STEP trials included patients who required extended escalation periods, and they still achieved significant weight loss once they reached their tolerated maintenance dose [1].

Who Can Use Wegovy? UK Prescribing Criteria Explained

Wegovy is licensed in the UK for adults with a BMI of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea. NICE guidance recommends semaglutide as part of a comprehensive weight management programme including dietary modification and increased physical activity [3].

During your free online consultation, our UK prescriber will calculate your BMI, review your medical history, and assess any contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. The assessment takes under 3 minutes and includes questions about previous weight loss attempts and current medications.

Wegovy is not suitable during pregnancy or breastfeeding, and should be discontinued at least 2 months before planned conception due to the long washout period of semaglutide. Your prescriber will discuss all relevant safety considerations before approving your prescription.

How to Order Wegovy from Cured Pharmacy

Start by completing our online clinical assessment—a secure questionnaire reviewed by a UK-registered prescriber, typically within 2-3 hours during working days. You'll answer questions about your weight history, current health conditions, medications, and weight loss goals to ensure Wegovy is safe and appropriate for you.

If approved, you'll receive a confirmation email with your prescription details and delivery timeline. Orders placed before 3pm Monday to Thursday dispatch the same day in our specialist cold-chain packaging, arriving the next working day. Friday orders are delivered Saturday to minimise weekend storage time.

Your first delivery includes the Wegovy pen with built-in needles, an NHS patient information leaflet, and instructions for subcutaneous injection technique. Our pharmacy team is available on (+44) 116 4646009 if you have questions about administration, storage, or side effect management during your treatment.

Ongoing Prescriptions and Automatic Refills

Wegovy requires a new prescription every 28 days under UK regulations. We'll send you a reminder email 5 days before your next dose is due, with a link to request your continuation prescription. Your prescriber will review your progress and any side effects before approving the next supply.

This monthly check-in ensures your treatment remains clinically appropriate and allows dose adjustments if needed. Patients who achieve their target weight or experience persistent side effects may require treatment modification, which our prescribers manage through these regular reviews.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Novo Nordisk. (2023). Wegovy 2.4 mg Solution for Injection in Pre-filled Pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for Managing Overweight and Obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.